Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALBOCICLIB vs PANITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALBOCICLIB vs PANITUMUMAB: Safety Overview

Metric PALBOCICLIB PANITUMUMAB
Total FAERS Reports 91,024 10,876
Deaths Reported 11,066 1,666
Death Rate 12.2% 15.3%
Hospitalizations 13,442 3,121
Average Patient Age 66.0 yrs 63.0 yrs
% Female Patients 97.7% 36.9%
FDA Approval Date Feb 3, 2015 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Amgen Inc
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription